{"companyId":354153,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","fi","ja"],"companyName":"Orion Plc","headOfficeLocation":"Orionintie 1A, Espoo, 02200, Finland","presidentName":"Liisa Hurme","companySummary":null,"stockCode":"ORNBV","currency":"EUR","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["orionpharma.com"],"businessContents":["Human and veterinary pharmaceutical development and manufacturing","Active pharmaceutical ingredient manufacturing"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://stockanalysis.com/quote/HEL/ORNBV/company/","scoreAbout":100,"scoreBusiness":100,"scoreGroup":0,"scoreCustomer":0}]}